Kayothera
PrivateLast Round
Series A
Extension
Jul 19, 2023
Total Funding Raised
$8M
Momentum Score
50 /100
Company Overview
Kayothera is a biotechnology company that develops first-in-class, oral, small-molecule inhibitors of the retinoid nuclear receptor pathway for the treatment of cancer and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kayothera Comps
Public and private peers based on sector, stage, and business model.
Kayothera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 19, 2023 | ||||
| Grant | Jul 19, 2023 | ||||
| Series A | Mar 16, 2022 | ||||
| Seed | Mar 28, 2018 |
Key People
Founding team and executive leadership
Kayothera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerator Life Science Partners | Series A, Series A Extension |
| Foundation Venture Capital Group | Seed |
| New Jersey Health Foundation | Seed |
| NIH RADx | Grant |
| WRF Capital | Series A Extension |
| Pier 70 Ventures | Series A Extension |
| BioAdvance Capital | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 108% MoM, reaching 1.7K.
Kayothera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kayothera's valuation, stock price, and market status.
